Mallory Wessel

Sexton Biotechnologies announced today that it has raised $5 million in growth capital and is the first company incubated by Indianapolis-based Cook Regentec to secure outside investment capital and spin out as an independent biotechnology company. In addition to ongoing research and product development, Sexton Biotechnologies will expand and scalecommercialization of its portfolio of container closure and media supplementation tools for cell and gene therapy bioproduction.